Rankings
▼
Calendar
KURA (Kura Oncology, Inc.) Stock Financials & Earnings | Market Cap Arena
KURA
Kura Oncology, Inc.
Mkt Cap
$815M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$67M
Net Income (TTM)
-$279M
EPS (TTM)
-$3.18
Free Cash Flow (TTM)
-$71M
Gross Margin
94.6%
Op. Margin
-449.9%
Net Margin
-412.9%
FCF Margin
-104.8%
P/S Ratio (TTM)
12.1x
P/E Ratio (TTM)
—
YoY Rev Growth
+25.2%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$37M
Q2 23
$0
$0
-$40M
Q3 23
$0
-$216K
-$42M
Q4 23
$0
-$214K
-$47M
Q1 24
$0
-$234K
-$54M
Q2 24
$0
-$202K
-$56M
Q3 24
$0
$0
-$60M
Q4 24
$54M
$54M
-$22M
Q1 25
$14M
$14M
-$65M
Q2 25
$15M
$15M
-$73M
Q3 25
$21M
$18M
-$80M
Q4 25
$17M
$17M
-$86M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
15.1x
—
Q1 25
12.0x
—
Q2 25
9.8x
—
Q3 25
7.8x
—
Q4 25
12.1x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$36M
-$36M
Q2 23
-$26M
-$26M
Q3 23
-$29M
-$29M
Q4 23
-$34M
-$34M
Q1 24
-$49M
-$49M
Q2 24
-$43M
-$43M
Q3 24
-$43M
-$43M
Q4 24
$269M
$269M
Q1 25
-$72M
-$72M
Q2 25
-$29M
-$30M
Q3 25
-$81M
-$83M
Q4 25
$117M
$115M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$36K
Q2 23
$96K
Q3 23
$20K
Q4 23
$16K
Q1 24
$84K
Q2 24
$16K
Q3 24
$0
Q4 24
$372K
Q1 25
$292K
Q2 25
$1M
Q3 25
$3M
Q4 25
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+11.5%
Q2 23
—
+13.2%
Q3 23
—
+16.1%
Q4 23
—
+33.0%
Q1 24
—
+48.9%
Q2 24
—
+41.0%
Q3 24
—
+41.0%
Q4 24
—
+63.2%
Q1 25
—
+44.7%
Q2 25
—
+55.9%
Q3 25
—
+68.2%
Q4 25
-67.8%
+35.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$7M
—
Q2 23
$7M
—
Q3 23
$7M
—
Q4 23
$7M
—
Q1 24
$9M
—
Q2 24
$8M
—
Q3 24
$8M
—
Q4 24
$9M
16.0%
Q1 25
$8M
55.6%
Q2 25
$7M
45.5%
Q3 25
$11M
52.8%
Q4 25
$11M
65.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$25M
$11M
—
Q2 23
$28M
$12M
—
Q3 23
$29M
—
$13M
Q4 23
$33M
—
$14M
Q1 24
$36M
$18M
—
Q2 24
$40M
$17M
—
Q3 24
$42M
$18M
—
Q4 24
$52M
$24M
—
Q1 25
$56M
$23M
—
Q2 25
$63M
$25M
—
Q3 25
$68M
$33M
—
Q4 25
$64M
—
$39M
marketcaparena.com
Revenue Segments
Operating Segments
Quarter
Operating Segments
Q2 25
$15M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$27M
$379M
$406M
Q2 23
$49M
$428M
$477M
Q3 23
$29M
$424M
$453M
Q4 23
$37M
$387M
$424M
Q1 24
$42M
$486M
$527M
Q2 24
$45M
$446M
$492M
Q3 24
$49M
$406M
$455M
Q4 24
$224M
$503M
$727M
Q1 25
$51M
$607M
$658M
Q2 25
$82M
$549M
$631M
Q3 25
$95M
$454M
$550M
Q4 25
$149M
$518M
$667M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
68M
+0.9%
Q2 23
70M
+2.0%
Q3 23
77M
+10.7%
Q4 23
77M
+0.1%
Q1 24
84M
+8.5%
Q2 24
87M
+3.3%
Q3 24
87M
+0.4%
Q4 24
87M
+0.2%
Q1 25
87M
+0.3%
Q2 25
88M
+0.2%
Q3 25
88M
+0.1%
Q4 25
88M
+0.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
$0
21
FY 16
$0
22
FY 17
$0
31
FY 18
$0
43
FY 19
$0
60
FY 20
$0
89
FY 21
$0
121
FY 22
$0
133
FY 23
$0
142
FY 24
$281K
192
FY 25
$260K
260
marketcaparena.com